Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review

A Ciapponi, A Bardach, A Mazzoni, T Alconada… - Vaccine, 2021 - Elsevier
Background Rapid assessment of COVID-19 vaccine safety during pregnancy is urgently
needed. Methods We conducted a rapid systematic review, to evaluate the safety of COVID …

[HTML][HTML] Safety of COVID-19 vaccines during pregnancy: a systematic review and meta-analysis

A Ciapponi, M Berrueta, EPK Parker, A Bardach… - Vaccine, 2023 - Elsevier
Background Assessment of COVID-19 vaccines safety during pregnancy is urgently needed.
Methods We conducted a systematic review and meta-analysis to evaluate the safety of …

RSV infection in children hospitalised with severe lower respiratory tract infection in a low-middle-income setting: A cross-sectional observational study

N Morgan, H Buys, R Muloiwa - Plos one, 2023 - journals.plos.org
Introduction Low-and middle-income countries carry the largest burden of Respiratory
syncytial virus (RSV) disease, with most deaths occurring in these settings. This study aimed …

Future vaccines in pregnancy

D Vress - Best Practice & Research Clinical Obstetrics & …, 2021 - Elsevier
Vaccination in pregnancy provides an important opportunity to target illnesses that are
known to impact pregnant women, fetal development, and newborns in particular. The ability …

[HTML][HTML] Safety of COVID-19 vaccines, their components or their platforms for pregnant women: A rapid review

A Ciapponi, A Bardach, A Mazzoni, T Alconada… - medRxiv, 2021 - ncbi.nlm.nih.gov
Background Pregnant women with COVID-19 are at an increased risk of severe COVID-19
illness as well as adverse pregnancy and birth outcomes. Many countries are vaccinating or …

Passive Immunization Strategies to Prevent Severe Respiratory Syncytial Virus Infection Among Newborns and Young Infants

M Suryadevara - Journal of the Pediatric Infectious Diseases …, 2024 - academic.oup.com
Newborns and young infants are at risk for severe respiratory syncytial virus (RSV) lower
respiratory tract infection. Passive immunity is the mainstay of infection prevention in this …

[HTML][HTML] Identifying Cross-Utilization of RSV Vaccine Inventions across the Human and Veterinary Field

M Janse, SD Soekhradj, R de Jong… - Pathogens, 2023 - mdpi.com
The respiratory syncytial virus (RSV) has two main variants with similar impact, a human and
a bovine variant. The human respiratory syncytial virus (HRSV) is the most frequent cause of …

RSV awareness, risk perception, causes, and terms: Perspectives of pregnant and lactating women in Kenya to inform demand generation efforts for maternal RSV …

RJ Limaye, B Fesshaye, P Singh… - Human Vaccines & …, 2023 - Taylor & Francis
Respiratory syncytial virus (RSV) causes a substantial proportion of acute lower respiratory
tract infections (LRTI) among infants. In low-and middle-income countries, RSV may be …

[HTML][HTML] Year-to-year variation in attack rates could result in underpowered respiratory syncytial virus vaccine efficacy trials

MN Billard, J Wildenbeest, LJ Bont, H Nair… - Journal of Clinical …, 2022 - Elsevier
Objective Year-to-year variation of respiratory viruses may result in lower attack rates than
expected. We aimed to illustrate the impact of year-to-year variation in attack rates on the …

One Health in the Context of Global Health.: Collaboration between veterinary and human health domains in non-pandemic times.

EM Janse - 2024 - research.vu.nl
Historically, the oldest healers were often priests who cared for humans and animals, with
which integrative thinking about human and animal health began long ago. Nowadays …